Synchronicity Pharma
OverviewSuggest Edit
Synchronicity Pharma is a company that develops therapeutics focused on modulating circadian clock genes. Its cryptochrome modulator programs enable clock-based therapies across a range of disease areas, including oncology, metabolic and endocrine disorders, inflammatory and autoimmune diseases, and more.
| Type | Private | |
| Website | synchronicitypharma.com |
Latest Updates
| Employees (est.) (Apr 2020) | 3 | |
| Cybersecurity rating | C | More |
Key People/Management at Synchronicity Pharma
Glenn Batchelder
Executive Chairman
Jamie Cope
Senior Vice President, Research and Translational Medicine
Fred Craves
Director
Shu Kurosaki
Chief Financial Officer
Blair Jackson
Director
Synchronicity Pharma Online and Social Media Presence
Synchronicity Pharma's Trends
Synchronicity Pharma Frequently Asked Questions
Who are Synchronicity Pharma key executives?
Synchronicity Pharma's key executives are Glenn Batchelder, Jamie Cope and Fred Craves.
How many employees does Synchronicity Pharma have?
Synchronicity Pharma has 3 employees.
Who are Synchronicity Pharma competitors?
Competitors of Synchronicity Pharma include ImmuneSensor Therapeutics, Grindeks and Stamford Pharmaceuticals.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies